ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

ClinicalTrials.gov ID: NCT00822120

Public ClinicalTrials.gov record NCT00822120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma Using Early Interim FDG-PET Imaging

Study identification

NCT ID
NCT00822120
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
371 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2009
Primary completion
Apr 29, 2016
Completion
Jun 29, 2022
Last update posted
Aug 17, 2022

2009 – 2022

United States locations

U.S. sites
22
U.S. states
3
U.S. cities
20
Facility City State ZIP Site status
Arizona Cancer Center at University Medical Center North Tucson Arizona 85719
Arizona Cancer Center at University of Arizona Health Sciences Center Tucson Arizona 85724-5024
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Highlands Oncology Group - Springdale Rogers Arkansas 72758
Kaiser Permanente Medical Center - Anaheim/Orange County Anaheim California 92807
Kaiser Permanente - Deer Valley Antioch California 94531
Kaiser Permanente Medical Center - Baldwin Park Baldwin Park California 91706
Kaiser Permanente Medical Center - Bellflower Bellflower California 90706
City of Hope Comprehensive Cancer Center Duarte California 91010-3000
Kaiser Permanente Medical Center - Fontana Fontana California 92335
Kaiser Permanente - Fremont Fremont California 94538
Kaiser Permanente Fresno Medical Center Fresno California 93720
Kaiser Permanente Medical Center - Harbor City Harbor City California 90710
Kaiser Permanente Medical Center - Hayward Hayward California 94545
Kaiser Permanente - Irvine Irvine California 92618
Rebecca and John Moores UCSD Cancer Center La Jolla California 92093-0658
Kaiser Permanente Medical Center - Los Angeles Los Angeles California 90027
Kaiser Foundation Hospital - West Los Angeles Los Angeles California 90034
Kaiser Permanente Medical Center - Oakland Oakland California 94611
Kaiser Permanente Medical Group Panorama City California 91402
Kaiser Permanente Medical Center - Redwood City Redwood City California 94063
Kaiser Permanente Medical Center - Richmond Richmond California 94801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00822120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2022 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00822120 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →